Literature DB >> 1280543

Hydroxyethyl starch induced acquired von Willebrand's disease.

M Dalrymple-Hay1, R Aitchison, P Collins, M Sekhar, B Colvin.   

Abstract

Hydroxyethyl starch (HES) (Hespan, DuPont) is a widely used synthetic volume expander which in standard doses of up to 1.5l in 24 h has no significant effect on coagulation (Munsch et al. 1988). However, the data sheet states that in large volumes HES may alter the coagulation mechanism. We now report a case of HES induced acquired von Willebrand's disease (vWD) in which severe bleeding occurred.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280543     DOI: 10.1111/j.1365-2257.1992.tb00367.x

Source DB:  PubMed          Journal:  Clin Lab Haematol        ISSN: 0141-9854


  4 in total

1.  Fluid therapy with hydroxyethyl starch for massive blood loss during surgery.

Authors:  Toshinari Suzuki; Hideki Miyao; Katsuo Terui; Kaoru Koyama; Michio Shiibashi
Journal:  J Anesth       Date:  2010-03-26       Impact factor: 2.078

Review 2.  Acquired von Willebrand syndrome: its pathophysiology, laboratory features and management.

Authors:  Hiroshi Mohri
Journal:  J Thromb Thrombolysis       Date:  2003-06       Impact factor: 2.300

Review 3.  [Fluid resuscitation in hemorrhage].

Authors:  M Roessler; K Bode; M Bauer
Journal:  Anaesthesist       Date:  2014-10       Impact factor: 1.041

4.  Synthetic colloid resuscitation in severely injured patients: analysis of a nationwide trauma registry (TraumaRegister DGU).

Authors:  Peter Hilbert-Carius; Daniel Schwarzkopf; Konrad Reinhart; Christiane S Hartog; Rolf Lefering; Michael Bernhard; Manuel F Struck
Journal:  Sci Rep       Date:  2018-08-01       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.